SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 138 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,209,796 | +95.8% | 138,832 | +122.1% | 0.00% | +100.0% |
| Q2 2023 | $1,639,170 | +251.5% | 62,516 | +245.1% | 0.00% | +100.0% |
| Q1 2023 | $466,306 | +14.8% | 18,116 | +16.0% | 0.00% | 0.0% |
| Q4 2022 | $406,172 | -4.2% | 15,616 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $424,000 | +10.4% | 15,616 | 0.0% | 0.00% | – |
| Q2 2022 | $384,000 | -68.2% | 15,616 | -27.1% | 0.00% | -100.0% |
| Q1 2022 | $1,209,000 | -8.9% | 21,416 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,327,000 | -2.4% | 21,416 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,359,000 | -25.9% | 21,416 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $1,835,000 | +16.4% | 21,416 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,576,000 | +11.9% | 21,416 | +10.2% | 0.00% | 0.0% |
| Q4 2020 | $1,409,000 | – | 19,436 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |